Literature DB >> 22138203

[Therapeutic compliance in patients with arterial hypertension and type 2 diabetes mellitus].

M L Gutiérrez-Angulo1, P Lopetegi-Uranga, I Sánchez-Martín, M Garaigordobil-Landazabal.   

Abstract

OBJECTIVE: 1) To determine gender differences regarding therapeutic adherence in patients with arterial hypertension and type 2 diabetes mellitus. 2) To detect differences in terms of age. 3) To determine existing relationships in patient compliance levels between Morisky-Green's test, Batalla's test and the pill count expressed as a percentage of compliance.
METHOD: Descriptive, transversal study, carried out for a period of 7 months in the Primary Health Care, Health Centre in Rentería-Beraun (Guipúzcoa), Basque Health Service (Osakidetza), with an incidental sample of 100 patients diagnosed with hypertension and type 2 diabetes mellitus and receiving oral treatment. Principal variables: age, gender. Conditioning variables: years of evolution of each pathology, number of prescribed medicines, time lapse of prescription collection, Morisky-Green's test, Batalla's test and pill count.
RESULTS: The statistical analysis yielded similar compliance for men and women, and for different age groups (Morisky-Green and pill count). Approximately 50% of the patients had adequate compliance according to at least one of the 3 tests. A greater relationship was found between Morisky-Green's test and the pill count method, and medication adherence improved when knowledge of the disease increased, and when the number of prescribed pills became smaller.
CONCLUSIONS: Adherence varies according to the evaluation tool used, non-adherence is high and knowledge of the disease helps compliance. This suggests the convenience of systematically reviewing treatments and supplying more information to patients.
Copyright © 2011 SECA. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138203     DOI: 10.1016/j.cali.2011.09.008

Source DB:  PubMed          Journal:  Rev Calid Asist        ISSN: 1134-282X


  5 in total

Review 1.  Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments.

Authors:  Beatriz Pérez-Escamilla; Lucía Franco-Trigo; Joanna C Moullin; Fernando Martínez-Martínez; José P García-Corpas
Journal:  Patient Prefer Adherence       Date:  2015-04-13       Impact factor: 2.711

2.  Medicines Compliance and Reimbursement Level in Portugal.

Authors:  Maria da Conceição Constantino Portela; Adalberto Campos Fernandes
Journal:  Health Serv Res Manag Epidemiol       Date:  2015-08-27

3.  Patients' Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study.

Authors:  Rocío Zamanillo-Campos; Maria Jesús Serrano-Ripoll; Joana Maria Taltavull-Aparicio; Elena Gervilla-García; Joana Ripoll; Maria Antonia Fiol-deRoque; Anne-Marie Boylan; Ignacio Ricci-Cabello
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

4.  Perspectives and Views of Primary Care Professionals Regarding DiabeText, a New mHealth Intervention to Support Adherence to Antidiabetic Medication in Spain: A Qualitative Study.

Authors:  Rocío Zamanillo-Campos; Maria Jesús Serrano-Ripoll; Joana Maria Taltavull-Aparicio; Elena Gervilla-García; Joana Ripoll; Maria Antonia Fiol-deRoque; Anne-Marie Boylan; Ignacio Ricci-Cabello
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

5.  Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients.

Authors:  Ivo Abraham; Yoleen Van Camp; Lorenzo Villa; Kris Denhaerynck; Diana Sun; Stefaan Vancayzeele; Heidi Brié; Ann Aerts; Christine Hermans; Karen MacDonald
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-12       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.